Bioventix PLC (AIM:BVXP)
London · Delayed Price · Currency is GBP · Price in GBX 1,830.00
-70.00 (-3.68%)
At close: Dec 5, 2025
Bioventix Market Cap
Bioventix has a market cap or net worth of 95.61 million as of December 5, 2025. Its market cap has decreased by -51.15% in one year.
Market Cap
95.61M
Enterprise Value
90.54M
Revenue
13.12M
Ranking
n/a
PE Ratio
12.77
Stock Price
1,830.00
Market Cap Chart
Since April 8, 2010, Bioventix's market cap has increased from 9.85M to 95.61M, an increase of 870.96%. That is a compound annual growth rate of 15.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 95.61M | -42.30% |
| Dec 31, 2024 | 165.72M | -26.16% |
| Dec 29, 2023 | 224.45M | 7.98% |
| Dec 30, 2022 | 207.85M | 17.35% |
| Dec 31, 2021 | 177.12M | -22.46% |
| Dec 31, 2020 | 228.43M | 34.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.00B |
| GSK plc | 73.57B |
| Haleon | 32.85B |
| Smith & Nephew | 10.46B |
| Convatec Group | 4.54B |
| Hikma Pharmaceuticals | 3.49B |
| HUTCHMED (China) | 1.85B |
| Genus | 1.73B |